Alligator Bioscience AB Aktier o.N.

Sector and Industry

Healthcare, Healthcare Services

Performance (1Y)

96.03%

Market Cap

-

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.17 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
UnitedHealth Group Inc.254.66 Bil.396.73 Bil.24.94
-19.75 %
0.00
-
Thermo Fisher Scientific Inc.185.62 Bil.39.50 Bil.32.67
+1.45 %
0.00
-
Danaher Corp.137.79 Bil.21.78 Bil.45.36
-11.47 %
0.00
-
McKesson Corporation90.13 Bil.348.09 Bil.22.55
+33.83 %
0.00
-
HCA Healthcare Inc.89.28 Bil.67.01 Bil.16.48
+12.93 %
0.00
-
Elevance Health Inc.65.88 Bil.176.51 Bil.13.91
-9.22 %
0.00
-
The Cigna Group61.74 Bil.243.65 Bil.12.41
+66.33 %
0.00
-
Cencora Inc.51.58 Bil.291.15 Bil.39.26
+1.16 %
0.00
-
IDEXX Laboratories Inc.45.92 Bil.3.81 Bil.51.74
+14.41 %
0.00
-
Zoetis Inc.45.52 Bil.8.39 Bil.20.89
+3.10 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.018 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 04:33:59 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.0180.018
PREV. DAY'S PRICE0.018 (07/16)
CHANGE DAY BEFORE
+0.00
0.00 %
52 WEEK HIGH / LOW0.55 (09/26)0.0001 (01/14)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-1.15-0.66-0.17--
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
-----
PRICE - BOOK RATIO
38.24-2.15--
PRICE - SALES RATIO
5.323.1718.04--
PRICE - CASH FLOW RATIO
-----
Further Key Figures

Master Data

WKN
A41BED
ISIN
SE0024173637
SYMBOL
7AL0
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
ALLIGATOR BIOSC. AB O.N.
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Services
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
13.92 %
8,900.00 %
-44.79 %
17,900.00 %
-96.03 %
-99.94 %
-100.00 %
-50.82 %
HIGH0.020.020.070.070.55133.00615.640.07
LOW0.020.000.000.000.000.000.000.00

Dividende

pro Aktie
ALLIGATOR BIOSC. AB O.N. does not deliver dividend information

Company profile

Alligator Bioscience AB is a biotechnology company, which engages in the development of novel immuno-oncology drugs. The firm specializes in the development of tumor-directed immunotherapies. Its pipeline includes Mitazalimab, ATOR-1017, ALG.APV-527, Neo-X-Prime, and other research projects. The company was founded by Carl Arne Krister Borrebaeck in 2001 and is headquartered in Lund, Sweden.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.